Electrical acupuncture for treating incontinence after prostate surgery
Official title: The Study of Electrical Acupuncture Stimulation Therapy for Postprostatectomy Incontinence
Run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT04972669 · Data updated 2026-11-12
This study is testing if electrical acupuncture can help men who have trouble controlling their urine after prostate surgery feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 75 Years |
| Sex | Men only |
| Enrollment | 110 (estimated) |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | March 1, 2021 |
| Main results expected | December 20, 2024 |
| Study ends | March 20, 2025 |
| Registry record updated | March 17, 2025 |
| Trial ID | NCT04972669 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men who have localized prostate cancer and have undergone prostatectomy within the last 4-6 weeks, experiencing incontinence post-surgery.
✕Probably not a fit
Patients with a history of hormonal therapy, previous pelvic surgery, or pre-existing incontinence prior to prostatectomy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of electrical acupuncture stimulation therapy for patients suffering from postprostatectomy incontinence, a common issue affecting over 50% of individuals after prostate surgery. The study builds on preliminary experiments that suggested potential benefits of this therapy for urinary incontinence. Participants will be randomly assigned to receive either the active treatment or a sham acupuncture intervention to assess safety and efficacy. The trial aims to provide a more effective treatment option for those struggling with incontinence following prostatectomy.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the quality of life for patients experiencing incontinence after prostate surgery.
How similar studies have gone: Previous studies have shown positive outcomes for electrical acupuncture in treating various types of urinary incontinence, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * localized prostate cancer (stage: cT1-cT2, N0, M0) * 4-6weeks after prostatectomy * postprostatectomy prostate specific antigen (PSA) test below cured level * incontinence one month after surgery * ECOG score:0-1 Exclusion Criteria: * history of neoadjuvant hormonal therapy * history of transurethral resection of the prostate (TUPR) * history of operation on pelvis * history of incontinence before prostatectomy
Where it's running
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Xuefeng Qiu
- Email: hydewoods@163.com
- Phone: 13776509416
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acupuncture plus vitamin B12 for diabetic heart nerve damage
This study tests whether adding acupuncture to standard care and vitamin B12 can help adults with type 2 diabetes who have damaged the nerves that control the heart.
-
Bone marrow cells plus Bio-Oss graft for repairing severe jawbone defects
This study tests whether using a patient’s own bone marrow–derived mononuclear cells mixed with Bio-Oss graft can repair severe maxillofacial bone defects in adults aged 18-60.
-
Sintilimab with NALIRIFOX or GP as first-line treatment for metastatic biliary tract cancer
This study tests whether adding sintilimab to either NALIRIFOX or gemcitabine‑cisplatin can help people with metastatic biliary tract cancer who have not had prior systemic therapy.
-
Liposomal irinotecan with 5-FU/LV and sintilimab plus SBRT for unresectable biliary tract cancer
This trial tests whether combining liposomal irinotecan, 5-FU/LV, and sintilimab, followed by SBRT, can help patients with unresectable locally advanced biliary tract cancer become eligible for surgery or slow disease progression.
-
Ipsilateral vs Bilateral Biopsy for Prostate Cancer Diagnosis using MRI/Ultrasound Fusion
This study tests whether taking biopsy samples from only the same side as a MRI-detected lesion is as good as taking samples from both sides in men who are biopsy-naive and have a suspicious unilateral lesion.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.